TP53 and neoplasm: Importantly, this work highlighted a clinically relevant diagnostic pitfall: tumours with p53 loss by IHC but no detectable exonic mutation may harbour deleterious intronic splice variants, reinforcing the importance of sequencing beyond coding regions.